In Vitro and In Vivo Experimental Activities of Antifungal Agents against Fusarium solani
AUTOR(ES)
Guarro, J.
FONTE
American Society for Microbiology
RESUMO
In the treatment of disseminated Fusarium infections, amphotericin B either alone or in combination with flucytosine and rifampin is the drug therapy most frequently used. The efficacy of these antifungal drugs was evaluated in a murine disseminated-infection model, with five strains of Fusarium solani. All the treatments were clearly ineffective.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=89252Documentos Relacionados
- In Vitro Activities of New Antifungal Agents against Chaetomium spp. and Inoculum Standardization
- In Vitro Activities of New and Conventional Antifungal Agents against Clinical Scedosporium Isolates
- In Vitro Activities of Approved and Investigational Antifungal Agents against 44 Clinical Isolates of Basidiomycetous Fungi
- In Vitro Activities of Voriconazole in Combination with Three Other Antifungal Agents against Candida glabrata
- In Vitro Activities of Three Licensed Antifungal Agents against Spanish Clinical Isolates of Aspergillus spp.
